ATG2B and metabolic dysfunction-associated steatohepatitis: Including the current findings that a) Rg1 is a monomer of ginsenoside; b) After Rg1 treatment, NASH cells and mouse symptoms were improved through the miR-375-3p/ATG2B/PTEN-ATKT signaling pathway.